Financial Disclosure

Cytonics Raises $4.8M, Hits 8,000 Investors for A2M Therapy

Image
Cytonics Raises $4.8M, Hits 8,000 Investors for A2M Therapy

Jupiter, Florida – September 15, 2026 -- Cytonics Corporation has closed a financing campaign generating $4.8 million in gross proceeds, pushing its total capital raised to $47 million and expanding its investor base to approximately 8,000 shareholders.

Cytonics attracts 900 new investors as 35% of existing shareholders reinvest

The clinical-stage biotechnology company completed approximately 1,500 individual investments in the round, including roughly 900 first-time backers. Of the pre-raise shareholder base, 35% chose to invest again, according to the company. The raise brings cumulative funds secured through Regulation A and Regulation Crowdfunding offerings to $27 million.

Lee Equity Invests in Marwood Group, Names Ex-EY Exec CEO

Image
Lee Equity Invests in Marwood Group, Names Ex-EY Exec CEO

New York – September 15, 2026 -- Marwood Group, a healthcare-focused advisory and consulting firm, has secured a strategic investment from Lee Equity Partners to fund acquisitions and senior team hires as it expands beyond its core policy and reimbursement advisory business.

Chris Librizzi departs EY-Parthenon to take Marwood's CEO role

Librizzi joins Marwood after five years leading EY-Parthenon's US strategy consulting business. He previously built and led EY's firmwide corporate strategy function and sat on the company's US Board and Executive Committee. At EY-Parthenon, he oversaw diversification into new customer segments and offerings, developed new products and client solutions, and led senior hires and acquisition integrations.

Lightfield Raises $47M Series A to Build CRM for AI Agents

San Francisco – September 15, 2026 -- Lightfield has raised $47 million in a Series A funding round led by Andreessen Horowitz, with participation from Maverick Capital, Coatue, Audacious, Alumni Ventures, Greylock, and Lightspeed Venture Partners. More than 5,000 companies have signed up for the platform since its November 2025 launch, ranging from early-stage startups to scaling firms with hundreds of CRM users.

Lightfield targets a structural flaw in legacy CRM systems built for manual data entry

Traditional CRM platforms like Salesforce and HubSpot were designed for people to type data into fields, stages, and notes rather than for AI agents to reason from. When agents are layered onto these systems, they inherit incomplete fields, stale close dates, and notes reconstructed from memory, producing work that companies cannot verify.

Spartan Logistics Acquires Allen Logistics, Expands Ohio Footprint

Image
Spartan Logistics Acquires Allen Logistics, Expands Ohio Footprint

Whitehouse, Ohio – September 15, 2026 -- Spartan Logistics has acquired Allen Logistics, a warehousing operator in Whitehouse, Ohio, adding 100,000 square feet of capacity and pushing the company's Northwest Ohio footprint to 950,000 square feet. The deal became effective September 1, 2026, and brings Spartan's total warehousing space to 4.5 million square feet across its multi-state network.

Acquisition adds seventh Northwest Ohio warehouse to Spartan's network

The Allen Logistics facility, located at 6245 Industrial Drive in Whitehouse, gives Spartan direct access to Swanton, Napoleon, and Perrysburg, complementing its existing Toledo operations. Chief Executive Officer Steve Harmon said Toledo has been a key market for Spartan for years and that the deal represents a continued investment in the region.

Nanoramic Closes Series 2 at $250M Valuation, Led by Catalus Capital

Image
Nanoramic Closes Series 2 at $250M Valuation, Led by Catalus Capital

Boston – September 15, 2026 -- Nanoramic, Inc. has closed the first tranche of its Series 2 equity financing round at a pre-money valuation of $250 million, led by Catalus Capital with participation from GM Ventures and existing Series 1 investors.

Mass production shipments of Neocarbonix drive investor commitment

The capital injection arrives as Nanoramic scales mass production shipments of its Neocarbonix Slurry Precursor (NXSP), a drop-in battery manufacturing material now supplying programs with global battery manufacturers, automotive OEMs, consumer electronics firms, power tool makers, and defense contractors. Shipment volumes have grown over the past six months to meet rising customer demand, according to founder and CEO John Cooley.

Alex Rodriguez's A-Rod Corp Invests in Menswear Brand Jack Archer

New York – September 15, 2026 -- Jack Archer, the men's lifestyle brand that has dressed more than 400,000 customers since launching its signature Jetsetter Tech Pant, has secured an investment from Alex Rodriguez's A-Rod Corp, the companies announced.

A-Rod Corp Adds Jack Archer to a Portfolio Spanning More Than 40 Ventures

A-Rod Corp, the Miami-based multi-asset platform led by the 14-time MLB All-Star, deploys internal and external capital across more than 40 companies and partnerships valued at over $1 billion. Rodriguez said his investment criteria center on strong products, clearly defined customers and teams with a defined growth trajectory, citing Jack Archer as meeting each threshold.

Delta Consulting Group Acquires Osborne Partners, Expands to 179 Professionals

Washington and London – September 15, 2026 -- Delta Consulting Group, Inc. has acquired Osborne Partners Ltd., creating a combined advisory platform of 179 professionals across eight global offices. The transaction closed on August 14, 2026, though financial terms were not disclosed.

Combined firm operates from Washington, DC to Singapore

The merged entity maintains main offices in Washington, DC; New York; Toronto; Madrid; London; Mumbai; Dubai; and Singapore. Osborne Partners will operate during the transition period under the name Osborne Partners, A Delta Consulting Group Company.

Provident Sells 161,408-SF Arlington Logistics Center After 1-Month Lease-Up

Image
Provident Sells 161,408-SF Arlington Logistics Center After 1-Month Lease-Up

Dallas – September 15, 2026 -- Provident Industrial has sold A20 Logistics Center, a 161,408-square-foot industrial building in Arlington, Texas, to an institutional buyer, closing out a project that leased half its space within one month of delivery.

Provident completed construction in January 2026, twelve months after breaking ground

The developer broke ground on the project in January 2025 in partnership with Humphreys Fund IV, managed by Humphreys Capital. Located at 4601 Dr. Martin Luther King Jr. Drive, just south of I-20 next to Arlington Municipal Airport, the site sits roughly 30 minutes from downtown Dallas, downtown Fort Worth, and DFW International Airport.

Foundation 8 Secures $44.5M Loan for Phoenix Office Tower

Image
Foundation 8 Secures $44.5M Loan for Phoenix Office Tower

Phoenix – September 15, 2026 -- Foundation 8, LLC has closed a $44.5 million first mortgage loan with Hilco Global Real Estate Capital to refinance and reposition the office component of 333 N Central Avenue, a landmark mixed-use tower in Downtown Phoenix.

Loan refinances acquisition debt and funds leasing costs

The financing replaces existing acquisition debt and provides additional capital for leasing costs, tenant improvements, and capital improvements tied to Foundation 8's business plan for the property. The office component spans 246,490 square feet of Class AA space across the top eight floors, plus 2,522 square feet of ground-floor retail, rooftop amenity rights, and shared parking access. A separately owned 242-key Westin Hotel occupies the building's middle floors.

AEYE Health's FDA-Cleared AI Hits 99% Imageability in 1,200-Patient Trial

Image
AEYE Health's FDA-Cleared AI Hits 99% Imageability in 1,200-Patient Trial

New York – September 15, 2026 -- AEYE Health published peer-reviewed results in Frontiers in Digital Health confirming its FDA-cleared AEYE-DS system achieved over 99% imageability across three prospective, controlled pivotal trials involving more than 1,200 diabetic patients.

Trial data validate the clinical foundation behind AEYE-DS's two FDA clearances

The study, covering trials AEYE-1, AEYE-2 and AEYE-3, benchmarked the autonomous AI against reading center multi-expert clinical review. AEYE-DS requires only a single image per eye, works with both portable handheld and tabletop cameras, and rarely requires pupil dilation -- making it the only FDA-cleared portable autonomous solution for diabetic retinopathy on the market, according to the company.